{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:33:45Z","timestamp":1793961225926,"version":"4.8.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32 AI07140"],"award-info":[{"award-number":["T32 AI07140"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AI027757"],"award-info":[{"award-number":["P30 AI027757"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Most non-clinic based HIV pre-exposure prophylaxis (PrEP) programs require fingersticks to self-collect blood specimens for laboratory monitoring, a technique that often results in inadequate blood volume for quantitative syphilis and HIV serological testing. We evaluated the acceptability and feasibility of using the Tasso OnDemand\u2122 device as a self-sampling method for PrEP monitoring tests and compared results from samples obtained using the Tasso device to clinician-collected blood samples.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We enrolled study subjects online and in a sexual health clinic and HIV clinic in Seattle, WA, USA to assess the acceptability of blood self-sampling and preferences for home-based PrEP monitoring. We compared HIV antigen\/antibody, quantitative rapid plasma reagin and creatinine results in paired self-collected and clinical specimens collected from a subset of participants.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 141 participants, 124 (88%) were interested in collecting samples for PrEP monitoring at home. Among 48 who completed blood collections, 94% found the Tasso device easy to use and 95% felt they could perform self-sampling at home. Of 27 participants who used two devices, 100% collected sufficient blood to perform up to two tests while 33% collected sufficient serum for three tests. Agreement in test results between paired samples was high.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These pilot data suggest that using the Tasso self-collection device is acceptable and could feasibly be used to obtain serum specimens sufficient for guideline-recommended PrEP monitoring, though use of a larger volume device may be preferable.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07432-0","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T11:09:48Z","timestamp":1652440188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Feasibility of a novel self-collection method for blood samples and its acceptability for future home-based PrEP monitoring"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2962-754X","authenticated-orcid":false,"given":"Chase A.","family":"Cannon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena S.","family":"Ramchandani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,13]]},"reference":[{"issue":"3","key":"7432_CR1","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/cid\/ciz894","volume":"71","author":"DP Serota","year":"2020","unstructured":"Serota DP, Rosenberg ES, Sullivan PS, Thorne AL, Rolle C-PM, Del Rio C, et al. Pre-exposure prophylaxis uptake and discontinuation among young black men who have sex with men in Atlanta, Georgia: a prospective cohort study. Clin Infect Dis. 2020;71(3):574\u201382.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"7432_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/cid\/ciy160","volume":"67","author":"LK Rusie","year":"2018","unstructured":"Rusie LK, Orengo C, Burrell D, Ramachandran A, Houlberg M, Keglovitz K, et al. Preexposure prophylaxis initiation and retention in care over 5 years, 2012\u20132017: are quarterly visits too much? Clin Infect Dis. 2018;67(2):283\u20137.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"7432_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25250","volume":"22","author":"D Krakower","year":"2019","unstructured":"Krakower D, Maloney KM, Powell VE, Levine K, Grasso C, Melbourne K, et al. Patterns and clinical consequences of discontinuing HIV preexposure prophylaxis during primary care. J Int AIDS Soc. 2019;22(2): e25250.","journal-title":"J Int AIDS Soc"},{"issue":"12","key":"7432_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189794","volume":"12","author":"SA John","year":"2017","unstructured":"John SA, Rendina HJ, Grov C, Parsons JT. Home-based pre-exposure prophylaxis (PrEP) services for gay and bisexual men: an opportunity to address barriers to PrEP uptake and persistence. PLoS ONE. 2017;12(12): e0189794.","journal-title":"PLoS ONE"},{"issue":"1","key":"7432_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/QAI.0000000000001873","volume":"80","author":"ON Refugio","year":"2019","unstructured":"Refugio ON, Kimble MM, Silva CL, Lykens JE, Bannister C, Klausner JD. PrEPTECH: a telehealth-based initiation program for HIV pre-exposure prophylaxis in young men of color who have sex with men. A pilot study of feasibility. J Acquir Immune Defic Syndr. 2019;80(1):6.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"7432_CR6","unstructured":"Centers for Disease Control and Prevention: US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States\u20142017 Update: a clinical practice guideline [Internet]. 2018 Mar [cited 2019 Dec 6]. Available from: https:\/\/www.cdc.gov\/hiv\/pdf\/risk\/prep\/cdc-hiv-prep-guidelines-2017.pdf."},{"issue":"3","key":"7432_CR7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/cid\/ciy529","volume":"68","author":"AJ Siegler","year":"2019","unstructured":"Siegler AJ, Mayer KH, Liu AY, Patel RR, Ahlschlager LM, Kraft CS, et al. Developing and assessing the feasibility of a home-based preexposure prophylaxis monitoring and support program. Clin Infect Dis. 2019;68(3):501\u20134.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"7432_CR8","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1007\/s10461-021-03209-9","volume":"25","author":"EE Chasco","year":"2021","unstructured":"Chasco EE, Hoth AB, Cho H, Shafer C, Siegler AJ, Ohl ME. Mixed-methods evaluation of the incorporation of home specimen self-collection kits for laboratory testing in a telehealth program for HIV pre-exposure prophylaxis. AIDS Behav. 2021;25(8):2463\u201382.","journal-title":"AIDS Behav"},{"key":"7432_CR9","unstructured":"TASSO-SST [Internet]. Tasso Inc. [cited 2020 Aug 22]. Available from: https:\/\/www.tassoinc.com\/tasso-sst."},{"issue":"11","key":"7432_CR10","doi-asserted-by":"publisher","first-page":"715","DOI":"10.4155\/bio-2020-0119","volume":"12","author":"MN Fedoruk","year":"2020","unstructured":"Fedoruk MN. Virtual drug testing: redefining sample collection in a global pandemic. Bioanalysis. 2020;12(11):715\u20138.","journal-title":"Bioanalysis"},{"issue":"9","key":"7432_CR11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.4155\/bio-2021-0027","volume":"13","author":"KJ Williams","year":"2021","unstructured":"Williams KJ, Lutman J, McCaughey C, Fischer SK. Assessment of low volume sampling technologies: utility in nonclinical and clinical studies. Bioanalysis. 2021;13(9):679\u201391.","journal-title":"Bioanalysis"},{"issue":"9","key":"7432_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255841","volume":"16","author":"T Hendelman","year":"2021","unstructured":"Hendelman T, Chaudhary A, LeClair AC, van Leuven K, Chee J, Fink SL, et al. Self-collection of capillary blood using Tasso-SST devices for Anti-SARS-CoV-2 IgG antibody testing. PLoS ONE. 2021;16(9): e0255841.","journal-title":"PLoS ONE"},{"issue":"4","key":"7432_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1089\/apc.2017.0313","volume":"32","author":"JC Dombrowski","year":"2018","unstructured":"Dombrowski JC, Ramchandani M, Dhanireddy S, Harrington RD, Moore A, Golden MR. The max clinic: medical care designed to engage the hardest-to-reach persons living with HIV in Seattle and King County, Washington. AIDS Patient Care STDS. 2018;32(4):149\u201356.","journal-title":"AIDS Patient Care STDS"},{"issue":"2","key":"7432_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"7432_CR15","unstructured":"Tasso-SST Instructional Video [Internet]. [cited 2020 Feb 2]. Available from: https:\/\/www.tassoinc.com\/tasso-sst-video."},{"issue":"3","key":"7432_CR16","first-page":"140","volume":"64","author":"Centers for Disease Control and Prevention","year":"2015","unstructured":"Centers for Disease Control and Prevention. 2015 STD treatment guidelines. Morb Mortal Wkly Rep. 2015;64(3):140.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"7","key":"7432_CR17","doi-asserted-by":"publisher","first-page":"328","DOI":"10.4329\/wjr.v4.i7.328","volume":"4","author":"S Haneder","year":"2012","unstructured":"Haneder S. Evaluation of a handheld creatinine measurement device for real-time determination of serum creatinine in radiology departments. WJR. 2012;4(7):328.","journal-title":"WJR"},{"issue":"9","key":"7432_CR18","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2019.1343","volume":"321","author":"AS Fauci","year":"2019","unstructured":"Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV epidemic: a plan for the United States. JAMA. 2019;321(9):844\u20135.","journal-title":"JAMA"},{"issue":"1","key":"7432_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-020-05568-w","volume":"20","author":"J Vanhamel","year":"2020","unstructured":"Vanhamel J, Rotsaert A, Reyniers T, N\u00f6stlinger C, Laga M, Landeghem EV, et al. The current landscape of pre-exposure prophylaxis service delivery models for HIV prevention: a scoping review. BMC Health Serv Res. 2020;20(1):1\u201318.","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"7432_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3390\/jpm12020231","volume":"12","author":"K Dub\u00e9","year":"2022","unstructured":"Dub\u00e9 K, Eskaf S, Hastie E, Agarwal H, Henley L, Roebuck C, et al. Preliminary acceptability of a home-based peripheral blood collection device for viral load testing in the context of analytical treatment interruptions in HIV cure trials: results from a Nationwide Survey in the United States. JPM. 2022;12(2):231.","journal-title":"JPM"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07432-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07432-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07432-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T11:12:15Z","timestamp":1652440335000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07432-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,13]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7432"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07432-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,13]]},"assertion":[{"value":"11 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The pilot study was approved by the University of Washington\u2019s Human Subjects Division and institutional review board (STUDY00009004) and Public Health\u2014Seattle & King County\u2019s Research Administrative Review Committee []. All participants completed written or electronic informed consent to participate in all aspects of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Tasso, Inc. donated blood collection devices for this study. All authors have no competing financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"459"}}